Commitment to R&D strengthens Allergan product pipeline


Irvine, CA-When Allergan announced in January that it planned to spin off its optical medical device business into a separate company called Advanced Medical Optics (AMO), David E.I. Pyott, chairman, president, and CEO of Allergan, said the company would evolve into a specialty pharmaceutical company.

Related Videos
Jennifer Lim, MD, FARVO
Related Content
© 2023 MJH Life Sciences

All rights reserved.